{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:12:38Z","timestamp":1778922758099,"version":"3.51.4"},"reference-count":101,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["226817"],"award-info":[{"award-number":["226817"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-020435"],"award-info":[{"award-number":["INV-020435"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["CREATOR 206545"],"award-info":[{"award-number":["CREATOR 206545"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["P30-AI168034"],"award-info":[{"award-number":["P30-AI168034"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI161013"],"award-info":[{"award-number":["R01AI161013"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019C00071"],"award-info":[{"award-number":["75N93019C00071"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30-AI168034"],"award-info":[{"award-number":["P30-AI168034"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["CC2112"],"award-info":[{"award-number":["CC2112"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["219633"],"award-info":[{"award-number":["219633"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["211433"],"award-info":[{"award-number":["211433"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010438","name":"Francis Crick Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Microbe"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.lanmic.2025.101278","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T20:01:24Z","timestamp":1769198484000},"page":"101278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Controlled human infection with Mycobacterium tuberculosis: practical considerations for clinical trials"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2783-7540","authenticated-orcid":false,"given":"Chetan","family":"Seshadri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoAnne L","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Maiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Schnappinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2753-1800","authenticated-orcid":false,"given":"Robert J","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4470-3608","authenticated-orcid":false,"given":"Henry C","family":"Mwandumba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kondwani C","family":"Jambo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel F","family":"Hoft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Euzebiusz","family":"Jamrozik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah M","family":"Fortune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G","family":"Kublin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanmic.2025.101278_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0029-2016","article-title":"Pathology of tuberculosis: how the pathology of human tuberculosis informs and directs animal models","volume":"5","author":"Basaraba","year":"2017","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.lanmic.2025.101278_bib3","doi-asserted-by":"crossref","first-page":"e00505","DOI":"10.1128\/IAI.00505-17","article-title":"Rhesus macaques are more susceptible to progressive tuberculosis than cynomolgus macaques: a quantitative comparison","volume":"86","author":"Maiello","year":"2018","journal-title":"Infect Immun"},{"key":"10.1016\/j.lanmic.2025.101278_bib4","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.lanmic.2025.101278_bib5","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/ije\/dyv142","article-title":"Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review","volume":"44","author":"Kashangura","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.lanmic.2025.101278_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.18609\/vac\/2022.027","article-title":"The quest for vaccine-induced immune correlates of protection against tuberculosis","volume":"1","author":"Nemes","year":"2022","journal-title":"Vaccine Insights"},{"key":"10.1016\/j.lanmic.2025.101278_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/d44148-024-00301-9","article-title":"New avenues in the age old battle against TB","author":"Morris","year":"2024","journal-title":"Nature Africa"},{"key":"10.1016\/j.lanmic.2025.101278_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101429","article-title":"Human challenge trials in vaccine development","volume":"50","author":"Sekhar","year":"2020","journal-title":"Semin Immunol"},{"key":"10.1016\/j.lanmic.2025.101278_bib9","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/cid\/ciu078","article-title":"An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution","volume":"58","author":"Waddington","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101278_bib10","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1073\/pnas.1615324114","article-title":"Attenuated PfSPZ vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection","volume":"114","author":"Lyke","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lanmic.2025.101278_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1164\/rccm.201903-0607OC","article-title":"Nasal pneumococcal density is associated with microaspiration and heightened human alveolar macrophage responsiveness to bacterial pathogens","volume":"201","author":"Mitsi","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lanmic.2025.101278_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002622","article-title":"Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage","volume":"8","author":"Wright","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.lanmic.2025.101278_bib13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2666-5247(24)00025-9","article-title":"Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study","volume":"5","author":"Jackson","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.lanmic.2025.101278_bib14","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/infdis\/jit647","article-title":"Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination","volume":"209","author":"Harris","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101278_bib15","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1164\/rccm.201908-1580OC","article-title":"A human lung challenge model to evaluate the safety and immunogenicity of PPD and live Bacillus Calmette-Gu\u00e9rin","volume":"201","author":"Davids","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lanmic.2025.101278_bib16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-2958.2002.03237.x","article-title":"Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti","volume":"46","author":"Pym","year":"2002","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.lanmic.2025.101278_bib17","first-page":"511","article-title":"Infectiousness of air from a tuberculosis ward. Ultraviolet irradiation of infected air: comparative infectiousness of different patients","volume":"85","author":"Riley","year":"1962","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.lanmic.2025.101278_bib18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/bioe.12802","article-title":"Ethical issues surrounding controlled human infection challenge studies in endemic low-and middle-income countries","volume":"34","author":"Jamrozik","year":"2020","journal-title":"Bioethics"},{"key":"10.1016\/j.lanmic.2025.101278_bib21","article-title":"Exploring the ethics of tuberculosis human challenge models","author":"Rohrig","year":"2023","journal-title":"J Med Ethics"},{"key":"10.1016\/j.lanmic.2025.101278_bib22","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/bioe.12794","article-title":"Judging the social value of controlled human infection studies","volume":"34","author":"Rid","year":"2020","journal-title":"Bioethics"},{"key":"10.1016\/j.lanmic.2025.101278_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12910-020-0454-y","article-title":"Stakeholder views on the acceptability of human infection studies in Malawi","volume":"21","author":"Kapumba","year":"2020","journal-title":"BMC Med Ethics"},{"key":"10.1016\/j.lanmic.2025.101278_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.12688\/wellcomeopenres.12256.1","article-title":"A framework for controlled human infection model (CHIM) studies in Malawi: report of a Wellcome Trust workshop on CHIM in Low Income Countries held in Blantyre, Malawi","volume":"2","author":"Gordon","year":"2017","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.lanmic.2025.101278_bib25","doi-asserted-by":"crossref","first-page":"e683","DOI":"10.1016\/S2666-5247(23)00178-7","article-title":"Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage of Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a randomised controlled trial and controlled human infection study","volume":"4","author":"Dula","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.lanmic.2025.101278_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.12688\/wellcomeopenres.19949.1","article-title":"Experimental pneumococcal carriage in people living with HIV in Malawi: the first controlled human infection model in a key at-risk population","volume":"9","author":"Doherty","year":"2024","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.lanmic.2025.101278_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103579","article-title":"A feasibility study of controlled human infection with Streptococcus pneumoniae in Malawi","volume":"72","author":"Morton","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.lanmic.2025.101278_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.12688\/wellcomeopenres.18767.2","article-title":"Practical considerations for a TB controlled human infection model (TB-CHIM); the case for TB-CHIM in Africa, a systematic review of the literature and report of 2 workshop discussions in UK and Malawi","volume":"8","author":"Gordon","year":"2023","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.lanmic.2025.101278_bib29","doi-asserted-by":"crossref","first-page":"e457","DOI":"10.1093\/infdis\/jiae238","article-title":"Review of current tuberculosis human infection studies for use in accelerating tuberculosis vaccine development: a meeting report","volume":"230","author":"Balasingam","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101278_bib30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/bioe.12781","article-title":"Deliberately infecting healthy volunteers with malaria parasites: perceptions and experiences of participants and other stakeholders in a Kenyan-based malaria infection study","volume":"34","author":"Jao","year":"2020","journal-title":"Bioethics"},{"key":"10.1016\/j.lanmic.2025.101278_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.12688\/wellcomeopenres.16587.1","article-title":"\u201cAt first, I was very afraid\u201d\u2014a qualitative description of participants\u2019 views and experiences in the first human infection study in Malawi","volume":"6","author":"Mtunthama Toto","year":"2021","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.lanmic.2025.101278_bib32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.12688\/wellcomeopenres.14668.2","article-title":"A Malawi guideline for research study participant remuneration","volume":"3","author":"Gordon","year":"2018","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.lanmic.2025.101278_bib33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41564-024-01913-5","article-title":"Engineered Mycobacterium tuberculosis triple-kill-switch strain provides controlled tuberculosis infection in animal models","volume":"10","author":"Wang","year":"2025","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.lanmic.2025.101278_bib34","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.811","article-title":"Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection","volume":"43","author":"Ford","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.lanmic.2025.101278_bib35","series-title":"Trimethoprim sulfamethoxazole","author":"Kemnic","year":"2022"},{"key":"10.1016\/j.lanmic.2025.101278_bib36","article-title":"Transmission and institutional infection control of tuberculosis","volume":"6","author":"Nardell","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.lanmic.2025.101278_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","article-title":"Prevention of tuberculosis in macaques after intravenous BCG immunization","volume":"577","author":"Darrah","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.lanmic.2025.101278_bib38","first-page":"8","article-title":"Incidence of complications in bronchoscopy. Multicentre prospective study of 20,986 bronchoscopies","volume":"71","author":"Facciolongo","year":"2009","journal-title":"Monaldi Arch Chest Dis"},{"key":"10.1016\/j.lanmic.2025.101278_bib39","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/CVI.00289-15","article-title":"Evaluation of the immunogenicity of Mycobacterium bovis BCG delivered by aerosol to the lungs of macaques","volume":"22","author":"White","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.lanmic.2025.101278_bib40","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1473-3099(24)00143-9","article-title":"Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial","volume":"24","author":"Satti","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101278_bib41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/00365548.2013.877157","article-title":"Laryngeal tuberculosis in the United States of America: a forgotten disease","volume":"46","author":"Benwill","year":"2014","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101278_bib42","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41541-025-01125-w","article-title":"Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development","volume":"10","author":"Siegal","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.lanmic.2025.101278_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007481","article-title":"Understanding paratyphoid infection: study protocol for the development of a human model of Salmonella enterica serovar Paratyphi A challenge in healthy adult volunteers","volume":"5","author":"McCullagh","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.lanmic.2025.101278_bib44","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1164\/rccm.201503-0542OC","article-title":"First human challenge testing of a pneumococcal vaccine. Double-blind randomized controlled trial","volume":"192","author":"Collins","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lanmic.2025.101278_bib45","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1016\/j.vaccine.2019.06.009","article-title":"Use of controlled human infection models (CHIMs) to support vaccine development: US regulatory considerations","volume":"37","author":"Ramanathan","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.lanmic.2025.101278_bib46","article-title":"Controlled human malaria infection: applications, advances, and challenges","volume":"86","author":"Stanisic","year":"2017","journal-title":"Infect Immun"},{"key":"10.1016\/j.lanmic.2025.101278_bib47","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.4049\/jimmunol.1800993","article-title":"The end of the binary era: revisiting the spectrum of tuberculosis","volume":"201","author":"Lin","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.lanmic.2025.101278_bib48","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1159\/000512531","article-title":"Post-tuberculosis lung disease: clinical review of an under-recognised global challenge","volume":"100","author":"Allwood","year":"2021","journal-title":"Respiration"},{"key":"10.1016\/j.lanmic.2025.101278_bib49","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S1473-3099(15)00068-7","article-title":"Design, recruitment, and microbiological considerations in human challenge studies","volume":"15","author":"Darton","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101278_bib50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MOG.0000000000000021","article-title":"Typhoid epidemiology, diagnostics and the human challenge model","volume":"30","author":"Darton","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.lanmic.2025.101278_bib51","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1128\/IAI.66.5.1968-1972.1998","article-title":"Validation of a volunteer model of cholera with frozen bacteria as the challenge","volume":"66","author":"Sack","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.lanmic.2025.101278_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109654","article-title":"Safety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-na\u00efve subjects at a new facility for sporozoite challenge","volume":"9","author":"Talley","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2025.101278_bib53","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/infdis\/jis012","article-title":"A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin","volume":"205","author":"Minassian","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101278_bib54","doi-asserted-by":"crossref","first-page":"695","DOI":"10.4049\/immunohorizons.2400053","article-title":"Probing dermal immunity to mycobacteria through a controlled human infection model","volume":"8","author":"Church","year":"2024","journal-title":"Immunohorizons"},{"key":"10.1016\/j.lanmic.2025.101278_bib55","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/infdis\/jiv482","article-title":"Optimization of a human Bacille Calmette-Gu\u00e9rin challenge model: a tool to evaluate antimycobacterial immunity","volume":"213","author":"Minhinnick","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101278_bib56","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/infdis\/jiad441","article-title":"Phase 1 open-label dose escalation trial for the development of a human Bacillus Calmette-Gu\u00e9rin challenge model for assessment of tuberculosis immunity in vivo","volume":"229","author":"Blazevic","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101278_bib57","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/S2666-5247(23)00289-6","article-title":"PET-CT-guided characterisation of progressive, preclinical tuberculosis infection and its association with low-level circulating Mycobacterium tuberculosis DNA in household contacts in Leicester, UK: a prospective cohort study","volume":"5","author":"Kim","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.lanmic.2025.101278_bib58","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1473-3099(19)30707-8","article-title":"Exhaled Mycobacterium tuberculosis output and detection of subclinical disease by face-mask sampling: prospective observational studies","volume":"20","author":"Williams","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101278_bib59","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0021-2023","article-title":"Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis","volume":"32","author":"Dhana","year":"2023","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.lanmic.2025.101278_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.lanmic.2025.101278_bib61","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1164\/rccm.201409-1704OC","article-title":"The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents","volume":"191","author":"Andrews","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lanmic.2025.101278_bib62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1473-3099(11)70210-9","article-title":"Predictive value of interferon-\u03b3 release assays for incident active tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Rangaka","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101278_bib63","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S2213-2600(17)30060-7","article-title":"Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study","volume":"5","author":"Andrews","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.lanmic.2025.101278_bib64","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1186\/s12879-021-06141-4","article-title":"Interferon-gamma release assay levels and risk of progression to active tuberculosis: a systematic review and dose-response meta-regression analysis","volume":"21","author":"Ledesma","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101278_bib65","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.chom.2023.05.006","article-title":"Airway T cells are a correlate of iv bacille Calmette-Guerin-mediated protection against tuberculosis in rhesus macaques","volume":"31","author":"Darrah","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.lanmic.2025.101278_bib66","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1172\/JCI77990","article-title":"Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response","volume":"125","author":"Adekambi","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lanmic.2025.101278_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1176","article-title":"Disease extent and anti-tubercular treatment response correlates with Mycobacterium tuberculosis-specific CD4 T-cell phenotype regardless of HIV-1 status","volume":"9","author":"Riou","year":"2020","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.lanmic.2025.101278_bib68","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1164\/rccm.202007-2686OC","article-title":"Antigen-specific T-cell activation distinguishes between recent and remote tuberculosis infection","volume":"203","author":"Mpande","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lanmic.2025.101278_bib69","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/s41590-018-0225-9","article-title":"The value of transcriptomics in advancing knowledge of the immune response and diagnosis in tuberculosis","volume":"19","author":"Singhania","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.lanmic.2025.101278_bib70","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/S2214-109X(23)00541-7","article-title":"Evaluation of the Xpert MTB host response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the Philippines, Uganda, and South Africa","volume":"12","author":"Gupta-Wright","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.lanmic.2025.101278_bib71","article-title":"Discovery and validation of a prognostic proteomic signature for tuberculosis progression: a prospective cohort study","volume":"16","author":"Penn-Nicholson","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.lanmic.2025.101278_bib72","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/cid\/ciy823","article-title":"Plasma biomarkers to detect prevalent or predict progressive tuberculosis associated with human immunodeficiency virus-1","volume":"69","author":"Lesosky","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101278_bib73","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1183\/13993003.01064-2015","article-title":"Use of chest radiography in the 22 highest tuberculosis burden countries","volume":"46","author":"Pande","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lanmic.2025.101278_bib74","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S2213-2600(23)00097-8","article-title":"The natural history of untreated pulmonary tuberculosis in adults: a systematic review and meta-analysis","volume":"11","author":"Sossen","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.lanmic.2025.101278_bib75","doi-asserted-by":"crossref","first-page":"e605","DOI":"10.1016\/S2589-7500(24)00118-3","article-title":"Computer-aided detection of tuberculosis from chest radiographs in a tuberculosis prevalence survey in South Africa: external validation and modelled impacts of commercially available artificial intelligence software","volume":"6","author":"Qin","year":"2024","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.lanmic.2025.101278_bib76","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13244-022-01255-y","article-title":"CT and 18F-FDG PET abnormalities in contacts with recent tuberculosis infections but negative chest X-ray","volume":"13","author":"Yoon","year":"2022","journal-title":"Insights Imaging"},{"key":"10.1016\/j.lanmic.2025.101278_bib77","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001749","article-title":"PET-CT for characterising TB infection (TBI) in immunocompetent subjects: a systematic review","volume":"72","author":"Kim","year":"2023","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.lanmic.2025.101278_bib78","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13550-020-0591-9","article-title":"Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response","volume":"10","author":"Malherbe","year":"2020","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.lanmic.2025.101278_bib79","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm.3412","article-title":"Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing","volume":"20","author":"Lin","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.lanmic.2025.101278_bib80","article-title":"PET CT identifies reactivation risk in cynomolgus macaques with latent","volume":"12","author":"Lin","year":"2016","journal-title":"M. tuberculosis. PLoS Pathog"},{"key":"10.1016\/j.lanmic.2025.101278_bib81","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1128\/IAI.01599-13","article-title":"Early changes by 18fluorodeoxyglucose positron emission tomography coregistered with computed tomography predict outcome after Mycobacterium tuberculosis infection in cynomolgus macaques","volume":"82","author":"Coleman","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.lanmic.2025.101278_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(24)00108-3","article-title":"Host and pathogen factors that influence variability of Mycobacterium tuberculosis lipid body content in sputum from patients with tuberculosis: an observational study","volume":"5","author":"Tarekegn","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.lanmic.2025.101278_bib83","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/thorax-2024-221470","article-title":"A structural and metabolic framework for classifying pre-clinical tuberculosis infection phenotypes using 18F-FDG PET-CT: a prospective cohort analysis following M. tuberculosis exposure","volume":"79","author":"Kim","year":"2024","journal-title":"Thorax"},{"key":"10.1016\/j.lanmic.2025.101278_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007337","article-title":"Lymph nodes are sites of prolonged bacterial persistence during Mycobacterium tuberculosis infection in macaques","volume":"14","author":"Ganchua","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.lanmic.2025.101278_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007305","article-title":"Concurrent infection with Mycobacterium tuberculosis confers robust protection against secondary infection in macaques","volume":"14","author":"Cadena","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.lanmic.2025.101278_bib86","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00312-17","article-title":"Digitally barcoding Mycobacterium tuberculosis reveals in vivo infection dynamics in the macaque model of tuberculosis","volume":"8","author":"Martin","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.lanmic.2025.101278_bib87","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1128\/AAC.00277-13","article-title":"Radiologic responses in cynomolgus macaques for assessing tuberculosis chemotherapy regimens","volume":"57","author":"Lin","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanmic.2025.101278_bib88","article-title":"High resolution imaging and five-year tuberculosis contact outcomes","author":"Esmail","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.lanmic.2025.101278_bib89","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1038\/s41467-024-48691-6","article-title":"Distributable, metabolic PET reporting of tuberculosis","volume":"15","author":"Khan","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.lanmic.2025.101278_bib90","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210388","article-title":"Cumulative radiation doses from recurrent PET-CT examinations","volume":"94","author":"Hosono","year":"2021","journal-title":"Br J Radiol"},{"key":"10.1016\/j.lanmic.2025.101278_bib91","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanmic.2025.101278_bib92","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1473-3099(24)00814-4","volume":"25","author":"Borges","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101278_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039909","article-title":"The HyVac4 subunit vaccine efficiently boosts BCG-primed anti-mycobacterial protective immunity","volume":"7","author":"Billeskov","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2025.101278_bib94","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI46252","article-title":"The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection","volume":"122","author":"Lin","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lanmic.2025.101278_bib95","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.82469","article-title":"Estimating the contribution of subclinical tuberculosis disease to transmission: an individual patient data analysis from prevalence surveys","volume":"12","author":"Emery","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.lanmic.2025.101278_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(24)00127-7","article-title":"Implications of subclinical tuberculosis for vaccine trial design and global effect","volume":"5","author":"Churchyard","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.lanmic.2025.101278_bib98","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa2034031","article-title":"A monoclonal antibody for malaria prevention","volume":"385","author":"Gaudinski","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanmic.2025.101278_bib99","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.mucimm.2024.06.010","article-title":"Inflammation of the nasal mucosa is associated with susceptibility to experimental pneumococcal challenge in older adults","volume":"17","author":"Urban","year":"2024","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.lanmic.2025.101278_bib100","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/infdis\/jiae341","article-title":"Natural carriage of Streptococcus pneumoniae is associated with increased experimental pneumococcal carriage but reduced conjugate vaccine efficacy in a human challenge model","volume":"231","author":"Galafa","year":"2025","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101278_bib101","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/cid\/ciy751","article-title":"Long-term stability of resistance to latent Mycobacterium tuberculosis infection in highly exposed tuberculosis household contacts in Kampala, Uganda","volume":"68","author":"Stein","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101278_bib102","first-page":"1351","article-title":"Early clearance of Mycobacterium tuberculosis: the INFECT case contact cohort study in Indonesia","volume":"221","author":"Verrall","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101278_bib103","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"A blood RNA signature for tuberculosis disease risk: a prospective cohort study","volume":"387","author":"Zak","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.lanmic.2025.101278_bib104","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb4757","article-title":"Mapping functional humoral correlates of protection against malaria challenge following RTS,S\/AS01 vaccination","volume":"12","author":"Suscovich","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.lanmic.2025.101278_bib105","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00008-21","article-title":"Controlled human infection models to accelerate vaccine development","volume":"35","author":"Choy","year":"2022","journal-title":"Clin Microbiol Rev"}],"container-title":["The Lancet Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266652472500206X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266652472500206X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:42:17Z","timestamp":1778920937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266652472500206X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":101,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S266652472500206X"],"URL":"https:\/\/doi.org\/10.1016\/j.lanmic.2025.101278","relation":{},"ISSN":["2666-5247"],"issn-type":[{"value":"2666-5247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controlled human infection with Mycobacterium tuberculosis: practical considerations for clinical trials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2025.101278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101278"}}